safety by nature depiction

safety by nature depiction

Intralytix, Inc.

is a biotechnology company focused on the discovery, production and marketing of bacteriophage-based products to control bacterial pathogens in environmental, food processing, and medical settings.

intralytix bacteriophage and Technology

intralytix bacteriophage and Food Safety

intralytix bacteriophage and Environmental Sanitation

Environmental Sanitation

intralytix bacteriophage and Veterinary Applications

Veterinary Applications

intralytix bacteriophage and Human Therapeutics

Human Therapeutics

intralytix bacteriophage and Dietary Supplements / Nutraceuticals

Dietary Supplements / Nutraceuticals

Bacteriophages (bacteria-eater: from the Greek phago meaning "to eat" or "to develop at the expense of") are the most abundant microorganisms on earth. They are natural enemies of disease causing bacteria. Lytic bacteriophages can very effectively kill their targeted specific bacteria without affecting the rest of the microbiome, ensuring an unprecedented level of safety for an antimicrobial.

Products

FortiPhage™

Bacteriophage-based preparation composed of three Myoviridae phages, each specifically targeting unwanted Escherichia coli.

ListShield™

Targets Listeria monocytogenes contamination in foods and food processing facilities.

U.S. Patent No. 7,507,571; 8,685,697

Star-K Kosher Certification : Kosher Certified

Islamic Food and Nutrition Council of America : Halal Certified

Organic Materials Review Institute : OMRI Listed®

FDA : 21 CFR 172.785

FSIS : Directive 7120.1

Health Canada : iLONO

Israel Ministry of Health : Ref: 70275202

EcoShield™ PX

Targets Shiga toxin producing Escherichia coli (STEC), including O157:H7 and all “big six” STEC serotypes.

U.S. Patent No. 7,625,741; 7,635,584; 7,625,556

Star-K Kosher Certification : Kosher Certified

Islamic Food and Nutrition Council of America : Halal Certified

Organic Materials Review Institute : OMRI Listed®

FSIS : Directive 7120.1

Health Canada : iLONO

Israel Ministry of Health : Ref: 70275202

SalmoFresh™

Targets contamination with selected, highly pathogenic Salmonella-serotypes in foods and food processing facilities.

U.S. Patent No. 7,674,467; 8,685,696

Star-K Kosher Certification : Kosher Certified

Islamic Food and Nutrition Council of America : Halal Certified

Organic Materials Review Institute : OMRI Listed®

FSIS : Directive 7120.1

Health Canada : iLONO

Israel Ministry of Health : Ref: 70275202

... Explore Full Product Catalog

Frequently Asked

How can I buy your bacteriophage products?

To purchase our bacteriophage products, please contact our sales team at sales@intralytix.com. Our team will be happy to provide more information and assist you with placing an order.

Where are your bacteriophage products manufactured?

Our bacteriophage products are manufactured right here in the USA. We take pride in producing high-quality, safe, and effective phage-based solutions.

What is a bacteriophage and how do they work?

Bacteriophages are the natural predator of bacteria. They are composed of genetic material surrounded by a protein coat, and and hijack the machinery of specific bacterial types to replicate themselves. This eventually causes the infected cells to burst and release new phages.

Do bacteriophages pose any risks to human health?

No, bacteriophages are non-pathogenic to humans as they only target bacterial cells, making them a safe therapeutic option.

How can I use bacteriophages?

Bacteriophages can be used in food processing and environmental applications to control bacterial contamination. See our human therapeutics page for information regarding phage therapy to treat bacterial infections.

... View All Frequently Asked Questions

Press Releases

Intralytix and Life Extension Collaborate to Advance Bacteriophage-Based Interventions in the VMS Space

Intralytix is excited to announce a new agreement with Life Extension to co-develop and commercialize a leading-edge phage-based nutraceutical aimed at expanding the role of bacteriophage technology within the vitamins, minerals, and supplements (VMS) sector.

Intralytix Receives FDA CVM Approval for Salmonella-Targeting Phage Preparation for Use in Pet Food Applications

Intralytix, Inc., a global leader in bacteriophage technology, announced today that it has received formal approval from the U.S. Food and Drug Administration’s Center for Veterinary Medicine (FDA CVM) for its Salmonella-specific bacteriophage preparation for use as a processing aid to help control S. enterica in pet food and ingredients for use in pet food.

Intralytix receives Safe Quality Food (SQF) certification

Intralytix announced today that it has received the highly coveted Safe Quality Food (SQF) certification for food manufacturing

Intralytix Receives FDA Regulatory Clearance for Expanded Use in Grain and Grain Products for Phage-Based E. coli Technology

Columbia, Maryland, USA – January 18, 2024. Intralytix, Inc. announced today that its food safety product, EcoShield™, has been granted a supplement to its GRAS (Generally Recognized As Safe) GRN 000834 status from the Food and Drug Administration (FDA)

News Around the World

Intralytix: Revolutionizing Healthcare and Food Safety with Cutting-Edge Bacteriophage Technology

The leadership team at Intralytix, Inc. shares how their groundbreaking bacteriophage technology is redefining healthcare and food safety—earning them a spot on our cover and recognition as one of the Top Fastest Growing Companies to Watch in 2025

Intralytix: Food Safety in the 21st Century: Bacteriophage-based Biocontrol as an Emerging Green Technology for Improving Food Safety

Phage biocontrol - an emerging modern technology now going mainstream for improving food safety.

Intralytix: Leveraging Phage Power for Food Safety

Intralytix once again selected as 2024 “Top Food Safety Solutions Provider” by the Food and Beverage Technology Review magazine.

H.C. Wainwright & Co., LLC hosts the First Annual Bacteriophage Conference

On November 30, 2022, H.C. Wainwright & Co., LLC hosted the First Annual Bacteriophage Conference to highlight what H.C. Wainwright & Co. believes to be a major pending inflection point in the field. Intralytix was one of the phage companies featured at the conference, with our President and CEO, Dr. Alexander "Sandro" Sulakvelidze presenting.

... Browse Latest News & Press Releases